(Q50940473)

25 March 2018

title

Adenine-induced chronic kidney and cardiovascular damage in rats (English)

1 reference

25 March 2018

3

Glenda Gobe

1 reference

25 March 2018

author name string

Vishal Diwan

series ordinal

1

1 reference

25 March 2018

Anand Mistry

series ordinal

2

1 reference

25 March 2018

Lindsay Brown

series ordinal

4

1 reference

25 March 2018

publication date

31 May 2013

1 reference

25 March 2018

Journal of Pharmacological and Toxicological Methods

published in

1 reference

25 March 2018

volume

68

1 reference

25 March 2018

issue

2

1 reference

25 March 2018

page(s)

197-207

1 reference

25 March 2018

Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-κB, cytokine production and oxidative stress.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

New model for adenine-induced chronic renal failure in mice, and the effect of gum acacia treatment thereon: comparison with rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Use of genetic mouse models in the study of diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Murine models of renal disease: possibilities and problems in studies using mutant mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Macrophages and progressive tubulointerstitial disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Uric acid: a novel mediator and marker of risk in chronic kidney disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Mechanisms of progression of chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Induction of chronic renal failure in the mouse: a new model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Identification of apoptosis in kidney tissue sections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Risk factors for end-stage renal disease: 25-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

First indications demonstrating the preventive effects of NZ-419, a novel intrinsic antioxidant, on the initiation and/or progression of chronic renal failure in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Systemic and renal effect of chronic omapatrilat in sodium-restricted, one-kidney, one-clip hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Allopurinol benefits left ventricular mass and endothelial dysfunction in chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Changes in the sodium and potassium transporters in the course of chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Effect of lowering uric acid on renal disease in the type 2 diabetic db/db mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Association between proteinuria and left ventricular mass index: a cardiac MRI study in patients with chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Measurement of glomerular filtration rate in the conscious rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Allopurinol, uric acid, and oxidative stress in cardiorenal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

The role of tubulointerstitial inflammation in the progression of chronic renal failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Lipid abnormalities and oxidized LDL in chronic kidney disease patients on hemodialysis and peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

NADH oxidase activity of human xanthine oxidoreductase--generation of superoxide anion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Thalidomide suppresses inflammation in adenine-induced CKD with uraemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

The podocyte's response to injury: role in proteinuria and glomerulosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Cardiovascular disease in an adenine-induced model of chronic kidney disease: the temporal link between vascular calcification and haemodynamic consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Histopathology and apoptosis in an animal model of reversible renal injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Rodent models of streptozotocin-induced diabetic nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Chronic kidney disease: definition and staging--an orthodox view.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Metabolic effects of dietary purine in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Animal model of adenine-induced chronic renal failure in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

Proteinuria and phenotypic change of proximal tubular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VASCN.2013.05.006

10.1016/J.VASCN.2013.05.006

7 January 2021

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018